HIGHLIGHTS
- who: Tomoyuki Makino and colleagues from the Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Takara-machi, Kanazawa, Japan have published the Article: Epidemiology and Prevention of Renal Cell Carcinoma, in the Journal: Cancers 2022, 14, 4059. of /2022/
- what: Incidentally, miRNAs were the most widely studied in terms of potential non-invasive biomarkers for RCC, while a 9 of 20 limited number of studies focused on DNA methylation. In this study, 25 metabolites were found to be robustly associated with risk after 1416 metabolites associated with the development . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.